George Ng

Insider Reports History

Entity
Individual
Location
C/O Sorrento Therapeutics, Inc., 6042 Cornerstone Court West, Suite B, San Diego, CA
Signature
/s/ Dan Dearborn as Power of Attorney for George Ng
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Ng:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 20K $54K $2.70 Jan 30, 2024 By Family Trust
Calidi Biotherapeutics, Inc. Director Common Stock 18.5K $33.4K $1.80 Sep 12, 2023 Direct
Calidi Biotherapeutics, Inc. Director Common Stock 9.55K $17.2K $1.80 Sep 12, 2023 By Peng Ventures, LLC
Kintara Therapeutics, Inc. Director Options (Right to Buy) 13.6K Oct 18, 2024 Direct
Kintara Therapeutics, Inc. Director Common Stock 0 Oct 18, 2024 Direct

Insider Reports Filed by George Ng

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 3 $0 4 Oct 22, 2024 Director
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 0 $0 3 Oct 22, 2024 Director
PCSA Processa Pharmaceuticals, Inc. Jan 30, 2024 1 $27K 4 Jan 31, 2024 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 12, 2023 1 $25K 4 Oct 12, 2023 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 10, 2023 1 $25K 4 Oct 10, 2023 Chief Executive Officer, Director
FLAG Calidi Biotherapeutics, Inc. Sep 12, 2023 0 $0 3 Sep 25, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 2 $0 4 Aug 9, 2023 Chief Executive Officer
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 0 $0 3 Aug 9, 2023 Chief Executive Officer